Cenexi appoints Jim McPherson as CEO

Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology

Biocon names Peter Bains as Group CEO

Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect

Takeda reiterates the need of equitable access to healthcare for universal impact

The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services

Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets

Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa

Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India

Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)

SMi Systems secures UK patent for breakthrough single molecule imaging capabilities

The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics

Ami Organics to supply additional API to Fermion

The product is expected to start contributing meaningfully to the revenue from FY25

Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform

The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades

Takara Bio Europe launches high-quality enzymes suitable for pre-clinical mRNA vaccine